Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Journal of Thrombosis and Haemostasis : JTH|October 5, 2017
Inherited thrombocytopenia caused by ANKRD26 mutations misdiagnosed and treated as myelodysplastic syndrome: report on two casesC Zaninetti, V Santini, M Tiniakou, et al.
Microscopia Electronica Y Biologia Celular : Organo Oficial De Las Sociedades Latinoamericana De Microscopia Electronica E Iberoamericana De Biologia Celular|January 1, 1990
Ultrastructural study of reaggregated culture of brainstem: synaptogenesisE M Lopez, S Peressini, M F Kubke, et al.
Haematologica|March 26, 1999
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institutionC L Balduini, R Guarnone, A Pecci, et al.
Hepatology (Baltimore, Md.)|August 8, 1998
Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligandW Gong, A Pecci, S Roth, et al.
Journal of Thrombosis and Haemostasis : JTH|May 5, 2005
Altered cytoskeleton organization in platelets from patients with MYH9-related diseaseI Canobbio, P Noris, A Pecci, et al.
Molecular Endocrinology (Baltimore, Md.)|August 14, 1999
The promoter of the rat 3-hydroxy-3-methylglutaryl coenzyme A reductase gene contains a tissue-specific estrogen-responsive regionL Di Croce, G P Vicent, A Pecci, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|December 14, 2016
Severe to profound deafness may be associated with MYH9-related disease: report of 4 patientsP Canzi, A Pecci, M Manfrin, et al.
Blood|November 24, 2001
Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasiaG Barosi, G Viarengo, A Pecci, et al.
Haematologica|March 21, 1998
Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromesR Invernizzi, A Pecci, G Rossi, et al.
Haematologica|December 24, 1997
Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromesR Invernizzi, A Pecci, G Rossi, et al.
Pageof 5